Please use this identifier to cite or link to this item:
Title: Antithrombotic Therapy After Transcatheter Aortic Valve Implantation
Author: Lugo, Leslie Marisol
Romaguera, Rafael
Gómez Hospital, Joan Antoni
Ferreiro, José Luis
Keywords: Pròtesis valvulars cardíaques
Heart valve prosthesis
Issue Date: 1-Jan-2020
Publisher: Radcliffe Cardiology
Abstract: The development of transcatheter aortic valve implantation has represented one of the greatest advances in the cardiology field in recent years and has changed clinical practice for patients with aortic stenosis. Despite the continuous improvement in operators' experience and techniques, and the development of new generation devices, thromboembolic and bleeding complications after transcatheter aortic valve implantation remain frequent, and are a major concern due to their negative impact on prognosis in this vulnerable population. In addition, the optimal antithrombotic regimen in this scenario is not known, and current recommendations are mostly empirical and not evidence based. The present review aims to provide an overview of the current status of knowledge, including relevant on-going randomised trials, on antithrombotic treatment strategies after transcatheter aortic valve implantation.
Note: Reproducció del document publicat a:
It is part of: European Cardiology Review, 2020, vol. 15, p. 54-61
Related resource:
Appears in Collections:Articles publicats en revistes (Ciències Clíniques)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
LugoLM.pdf790.43 kBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons